Conventional radiographic lymphography has been shown to play a significant role in the initial diagnosis, treatment planning, and follow-up of many diseases.
However, it remains a relatively difficult, time-consuming technique. It is also associated with definite morbidity and numerous potential complications. These factors have all motivated the search for an alternative diagnostic method for the study of the lymphatic system.
One approach has been the investigation of radiopharmaceuticals for lymphatic system imaging. Gold-198 radiocolloid has been used but has not found general acceptance. With the development of technetium-99m, it seemed evident that this isotope should be evaluated for use in radionuclide lymphography.
The objective of this study was to determine the relative efficacy of a recently developed radiopharmaceutical, technetium-99m "minicolloid", compared to a commercially available technetium-99m colloid for imaging the lymphatic system. Other purposes of this study were to determine the optimum dose to scan time for the radiopharmaceuticals, the effects of exercise on migration of the radiopharmaceutical through the lymphatic system, and the effects of the use of multiple injection sites on uptake of the radiopharmaceutical into the lymphatic channels. The use of local anesthetics and hyaluronidase was also considered.
Technetium-99m sulfur colloid was prepared utilizing the hydrogen sulfide method. Technetium-99m minicolloid is currently used as an effective bone marrow scanning agent. The physical characteristics of the technetium-99m isotope were found to be more ideal for effective lymphatic imaging than gold-198. This new colloid material, referred to as minicolloid because of its relatively small particle size, gave much better lymph node and lymph channel visualization than the commercially available colloid. The study also revealed better radiopharmaceutical uptake in the nodal system, which enabled the study of the lymphatic system on the same day of radiopharmaceutical administration. Dose to scan time was therefore short, thus allowing these nuclear medicine procedures during a single patient visit.
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ABSTRACT
The technique for lymphatic system evaluation by imaging with technetium-99m "minicolloid" is presented. Results from studies which compared the smaller particle radiocolloid with the commercially available radiopharmaceutical of the larger colloid particle size demonstrated the former to be a far superior agent for imaging the lymphatic system. This appears to be due to its more favorable migration through successive nodal groups. Other proven advantages of the minicolloid material were same-day imaging, lower absorbed dose, and better resolution. Radionuclide lymphography is expected to play an increasing role, in conjunction with radiographic lymphography, as larger numbers of patients suspected of lymphatic system disease are evaluated using the nuclear medicine techniques and approaches described.
I. INTRODUCTION
Conventional radiographic lymphography plays an important role in the initial diagnosis, treatment planning, and follow-up of many diseases. ' However While developing a clinically useful gamma scanning technique for our institu99m tion, the efficacy of the hydrogen sulfide preparation for lymphography ( ' Tc "minicolloid" currently employed for bone marrow scanning in our institutions 2, 10 ) was compared with that of certain commercial products. Other objectives of this study were to determine optimum dose to scan time, effects of exercise on migration of the radiopharmaceuticals and effects of multiple injection sites. In addition, the use of local anesthetics and hyaluronidase was considered.
n. MATERIALS AND METHODS 99m The basic difference between Tc sulfur colloid prepared by the hydrogen sulfide method and the colloids now available commercially is particle size. This hydrogen sulfide preparation is called "minicolloid" to make this distinction. Particle size, as determined by light scatter spectrophotometry, is heterogeneous (less than 0.1 micron) and shows no discrete particle size for the minicolloid. The majority of the minicol- The minicolloid and the NEN sulfur colloid were injected subcutaneously in the medial web spaces of the hind feet of six anesthetized beagle dogs. Approximately 1.5 mCi of each product were injected bilaterally. Serial counts were then obtained using a Nuclear-Chicago Pho/Gamma II HP camera. The disappearance of the radiopharmaceutical from the lower extremity was monitored by counting over the injection site and the popliteal lymph nodes. The appearance of the radiopharmaceutical in the pelvis and abdomen was monitored by counting over the iliolumbar nodal areas.
To study the effect of movement of the lower extremities on rate of radiopharmaceutical migration, relative counts were compared for two groups of animals, one group having its lower extremities exercised passively and the other being kept immobile. Tc eluate 3. 1-1/2 ml gelatin solution (10 mg/ml) 4. 1 ml 12 N HC1 (cone) 5. Bubble in H 2 S gas 5 min, stand 10 min 6. Bubble in Nn gas 5 min 7. Check with lead acetate paper for absence of H 9 S 8. Adjust pH to 5.0-6.0 with 5 N and 1 N NaOH 9. Filter through 0.22-micron membrane filter into sterile vial.
Key factors in successful compounding are:
1. Make gelatin solution by placing 200 mg gelatin powder in a beaker, add 20 ml water for injection, heat to gentle boil for 3 min, cool, adjust volume.to 20 ml, filter through 0.22-micron membrane filter into a series of sterile vials.
2. Follow order of additions.
3. Leave in acid state no longer than necessary.
4. Carefully avoid letting pH rise above 6. 0.
Finally, a preliminary evaluation in several human subjects was undertaken using a slightly modified comparative serial counting technique. Equivalent doses of 2. 0 mCi of the minicolloid and the NEN colloid were injected in the medial web spaces of each foot. The pelvic and abdominal nodal areas (ilioinguinal and periaortic) were then serially counted separately. The injection sites were counted serially without including node-bearing areas. Subjects were asked to ambulate between counts.
Additionally, four humans received injections in more than one web space on each side and some doses contained a local anesthetic.
III. RESULTS AND DISCUSSION
Comparison of minicolloid and NEN colloid. In the dog experiments, the minicolloid demonstrated more rapid hind extremity disappearance and iliolumbar appearance than did the NEN colloid (Figure 1 ). The shape of the iliolumbar appearance curves is of interest. For both products, there was a rapid increase in count rate followed by a plateau during which little change in activity occurred. The plateau represents the optimum imaging period; and, significantly, the minicolloid activity was several times that of the NEN colloid. The later gradual increase in count rate reflects lymphatic vascular recirculation with radioactivity detected from the abdominal viscera. The comparative results for minicolloid and NEN colloid in humans are summarized in Figure 3 . Both radiopharmaceuticals disappeared equally promptly from the injection site. In humans, the first node encountered after injection into the medial web space is in the ilioinguinal region, and a difference of less than a factor of two existed between the relative uptake of the two products in these nodes. However, a manyfold difference was evident in the later uptake in the periaortic region. These Tc minicolloid lies not in the more rapid initial uptake into the lymphatics but in the greater ability of the minicolloid to migrate through successive node levels. This is presumably due to its smaller particle size.
The less favorable activity levels achieved with the larger particle colloid in the peri- used and it was decided that it is not necessary with Tc minicolloid since uptake is rapid without it. As shown in this study, migrational limitations are not at the point of entry into the lymphatics but in the passage of colloid through successive node groups.
By using a radiopharmaceutical with high specific activity, without hyaluronidase or a local anesthetic, the injection volume is small (0,2-0.5 ml per injection) and may be better tolerated by patients. Dose preparation is simpler when fewer drugs are involved. As indicated by the time activity curves in Figure 3 , the dose to scan time is flexible; however, there is some advantage in scanning before recirculation occurs, e. g., at 90 to 150 minutes after injection. Potentially confusing background activity in liver, bowel and genitourinary organs is thereby avoided, but this has not been a major problem. Table n is a summary of our techniques for pedal studies. Table III . A dose of 2mCi per site has proven adequate for imaging although higher activities may be safely given.
Biological assumptions were that 20 percent of the administered dose would remain at the injection site and the rest would migrate through the lymphatics. Colloid reaching the systemic venous return localizes in the reticuloendothelial system. The absorbed dose to individual lymph nodes will vary depending on the percent localization and the size of the node. There are approximately 350 g of abdominopelvic lymphatics. Dose to scan time is short, which permits single visit studies.
The greatest common advantages of radionuclide lymphographic techniques derive from their simplicity. Only 5 minutes of the physician's time is required to inject the radiopharmaceutical through the subcutaneous or submucosal route. The remaining technician and equipment time needed to complete the procedure varies but is uniformly less than that required for studies involving radiographic contrast media.
Complications are virtually nonexistent. 3 ' 5 ' 6 The radionuclide techniques may be used in anatomical areas where adequate lymphatic vessels for cannulation are not present. These procedures also represent a more physiologic approach for studying lymphatic dynamics.
Most importantly, serial repetitions may be as easily carried out as the initial study. This is a distinct advantage over radiographic lymphograms in the long-term follow-up of patients. The relatively poor resolution is partially offset by the ability to assess change from one study to the next. The results of this study support the observations of others that assessment of the accuracy of radionuclide scanning must come from direct clinical observation and nodal biopsy rather than from comparison with radiographic lymphography. Radiographs have their own peculiar inaccuracies and are subject to significant variations in interpretation. »
